August 7, 2009
In a healthy immune system, there is a full range of CD4 cells (T-cells) that can fight different diseases. As HIV disease progresses, the number of CD4 cells drops. The first CD4 cells that HIV attacks are the ones that specifically fight HIV. Some types of CD4 cells can disappear, leaving gaps in the immune defenses. Immune restoration looks for ways to fill these gaps.
A healthy immune system can fight off opportunistic infections (OIs). Because these infections develop when CD4 cell levels are low, many researchers think that CD4 cell counts are a good measure of immune function. They believe that increases in CD4 cell counts are a sign of immune restoration. There is some disagreement on this point. (See "Are New CD4 cells As Good As Old?" below.)
When scientists thought that the thymus stopped working at a young age, they studied transplanting a human or animal thymus into someone with HIV. They also tried to stimulate the thymus using thymic hormones. These methods might still be important for older people with HIV.
One approach is called cell expansion. An individual's cells are multiplied outside the body, and then infused back into the body. A second approach is cell transfer. This involves giving a patient some immune cells from the patient's twin or an HIV-negative relative.
A third method uses cytokines. These are chemical messengers that support the immune response. The most work has been done on interleukin-2 (IL-2), which can lead to large increases in CD4 cells. Fact Sheet 482 has more information on IL-2.
Another approach is gene therapy. This involves changing the bone marrow cells that will travel to the thymus and become CD4 cells. Gene therapy tries to make the bone marrow cells immune to HIV infection.
Most people take medications to prevent opportunistic infections (See Fact Sheet 500) when their CD4 cell counts go below 200. However, if these people take ART and their CD4 cell counts climb back over 200, it is safe in most cases to stop taking medications to prevent these infections. Be sure to talk to your doctor before you stop taking any medication.
A combination of HIV vaccines and interleukin-2 (IL-2) increased anti-HIV immune responses and led to immune control of HIV for up to a year in one study. Fact Sheet 482 has more information on IL-2.
An "immune regulating hormone," Immunitin or HE2000, is being developed by Hollis-Eden Pharmaceuticals. It showed good results in a Phase II clinical trial.
When people with HIV start taking ART, their CD4 cell counts usually go up. At first, the new CD4 cells are probably copies of existing types of CD4 cells. If some "types" of CD4 cells were lost, they won't come back right away. This could leave some gaps in the body's immune defenses.
However, if HIV stays under control for a few years, the thymus might make new CD4 cells that could fill in these gaps and restore the immune system. Some of these CD4 cells might help control HIV infection.